Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Immunogenicity Case Studies to be Covered at PEGS – the essential protein engineering summitHear immunogenicity case studies by Amgen, Genentech, Eli Lilly, Biogen Idec, Bristol-Myers Squibb, Celltrion, GlaxoSmithKline, Teva, Shore, ENS-Cachan, and Johns Hopkins.
6th Annual Immunogenicity for Regulatory Success (May 7-8) Non-Clinical, Preclinical, and Clinical Strategies for Risk Assessment and Smooth Interaction with the Regulatory Authorities Topics: - Assays, Interpretation and Standards - Immune Complexes and Hypersensitivity - Immunogenicity Risk Assessment - Combination Therapy and Complex Mixtures of Drugs 2nd Annual Immunogenicity Prediction and Mitigation (May 8-9) Risk Factors, Predictive Tools and Immune Tolerance Approaches Topics: - Immunogenicity Reduction and Control - Prediction of Immunogenicity - Immunogenicity Reduction and Tolerance Induction - Risk Factors for Immunogenicity - Pysiological Effects of Protein Aggregation All the top commercial & academic companies will present on immunogenicity: Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi, lscimemi@healthtech.com. For full details and to register, visit www.pegsummit.com/ About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. www.chicorporate.com Contact: James Prudhomme Cambridge Healthtech Institute 781-972-5400 jprudhomme@healthtech.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|